These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. Cavedini P, Erzegovesi S, Ronchi P, Bellodi L. Eur Neuropsychopharmacol; 1997 Feb 01; 7(1):45-9. PubMed ID: 9088884 [Abstract] [Full Text] [Related]
31. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. Hewlett WA, Vinogradov S, Agras WS. J Clin Psychopharmacol; 1992 Dec 01; 12(6):420-30. PubMed ID: 1474179 [Abstract] [Full Text] [Related]
32. Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents? Mavissakalian M, Michelson L. J Nerv Ment Dis; 1983 May 01; 171(5):301-6. PubMed ID: 6343556 [Abstract] [Full Text] [Related]
33. An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder. Pizarro M, Fontenelle LF, Paravidino DC, Yücel M, Miguel EC, de Menezes GB. Expert Opin Pharmacother; 2014 Jul 01; 15(10):1391-401. PubMed ID: 24766145 [Abstract] [Full Text] [Related]
34. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M. Arch Gen Psychiatry; 1985 Oct 01; 42(10):977-83. PubMed ID: 3899048 [Abstract] [Full Text] [Related]
35. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Simeon JG, Thatte S, Wiggins D. Psychopharmacol Bull; 1990 Oct 01; 26(3):285-90. PubMed ID: 2274627 [Abstract] [Full Text] [Related]